Both in Biotechnology
Surrozen vs Tectonic Therapeutic
Over the past year SRZN returned +107.4% and TECX returned +8.4%; their daily moves had a correlation of 0.16.
SRZN +107.4% TECX +8.4%Growth of $1, one year, split-adjusted
| Metric | SRZN | TECX |
|---|---|---|
| Price | $29.04 | $19.78 |
| Market cap | $341.3M | $386.7M |
| Today | −1.43% | −3.51% |
| 1 month | −3.2% | −12.7% |
| 6 months | −13.6% | −31.9% |
| Year to date | +28.5% | −5.2% |
| 1 year | +113.7% | +6.2% |
| Revenue growth (YoY) | +408.6% | — |
| Gross margin | 100.0% | — |
| Net margin | 640.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 29.7× | — |
| Net cash | $102.0M | $226.9M |
| Dividend yield | — | — |
| Volatility (60d) | 174.0% | 67.2% |
| Short % of float | 37.0% | 19.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).